<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03852862</url>
  </required_header>
  <id_info>
    <org_study_id>2017/182/HP</org_study_id>
    <nct_id>NCT03852862</nct_id>
  </id_info>
  <brief_title>Double Regional Anesthesia in Video Assisted Thoracoscopy</brief_title>
  <acronym>DRAVATS</acronym>
  <official_title>Double Regional Anesthesia in Video Assisted Thoracoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monocentric, randomized, controlled, single-blind study who's aim is to demonstrate the
      efficacy of the association of paravertebral block and serratus plane block with
      paravertebral block alone
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 8, 2019</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of opioids drug administrated</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay in recovery room</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total duration of hospitalization</measure>
    <time_frame>during the 28 days postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Video Assisted Thoracoscopy</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Serratus plane block with paravertebral block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Association of Serratus plane block and paravertebral block for anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paravertebral block alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paravertebral block for anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Serratus plane block and paravertebral block</intervention_name>
    <description>Single Administration of 20 mL of ropivacaine for Serratus plane block (Intra-muscular injection) followed by a single administration of 20 ml ropivacaine for paravertebral block (T4 inter-vertebral injection)</description>
    <arm_group_label>Serratus plane block with paravertebral block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paravertebral block</intervention_name>
    <description>Single Administration of 20 ml of ropivacaine for paravertebral block (T4 inter-vertebral injection)</description>
    <arm_group_label>paravertebral block alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 18 to 75 years;

          -  Programmed for unilateral videothoracoscopy for anatomical resection (segmentectomy,
             lobectomy);

          -  Subject affiliated to a social security scheme;

          -  Subject having signed an informed consent

        Exclusion Criteria:

          -  Chronic treatment with opiates;

          -  Contraindication to administration of morphine;

          -  Allergy to local anesthetics or contraindications to the use of ropivacaine;

          -  Contraindication to the realization of paravertebral blocks and serratus;

          -  Pregnancy, breastfeeding;

          -  Severe obesity (BMI &gt; 40 kg/mÂ²);

          -  Renal impairment (GFR &lt; 30 mL/min) or known severe hepatic impairment;

          -  Difficulties of comprehension preventing the collection of consent and the realization
             of the study;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Melody DUSSEAUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie-Melody DUSSEAUX, MD</last_name>
    <phone>+3323288</phone>
    <phone_ext>8265</phone_ext>
    <email>Marie-Melody.Dusseaux@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT</last_name>
    <phone>+3323288</phone>
    <phone_ext>8265</phone_ext>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Melody DUSSEAUX, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>February 22, 2019</study_first_submitted>
  <study_first_submitted_qc>February 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2019</study_first_posted>
  <last_update_submitted>October 23, 2019</last_update_submitted>
  <last_update_submitted_qc>October 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

